Class Medicines Defect Information: Memantine 10mg Film-Coated Tablets, PL 20416/0260, (EL (20)A/11)

Published On:

25 February 2020

Published In:

Brief description of the problem

Crescent Pharma Ltd has informed us of a discrepancy on the product packaging for the above batches. The discrepancy relates to the incorrect quantity printed on one side (end flap) of the packs in error. The incorrect end flap states that the quantity of tablets within the pack is 30, however this is incorrect and should state 28 as per all other sides of the pack, (see Annex 1 in Class 4 medicines defect information: Memantine 10mg Film-Coated Tablets (EL (20)A/11)). The other product details on the pack including the name, strength and pharmaceutical form of the medicine are correct. .

Request a Callback with Our Specialist Team!

Leave your contact details along with a few lines about the nature of your enquiry and a specialist member of our team will get in touch.

The New CQC Framework – A Year in Review for Health and Social Care Providers